Home » SUN PHARMA TO DEMERGE R&D SECTION
SUN PHARMA TO DEMERGE R&D SECTION
The Baroda-based Sun Pharmaceutical Industries Ltd today said it had approved the demerger of the company's undertaking related to innovative research and development and new drug delivery systems to a new company. The board of directors approved the demerger date as April 1, 2006 at its meeting held on February 9, the company informed the stock exchanges.
The Hindu (http://www.hindu.com/thehindu/holnus/006200602101531.htm)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May